A polymorphism in the CYP17 gene is associated with prostate cancer risk.
Gsur A, Bernhofer G, Hinteregger S, Haidinger G, Schatzl G, Madersbacher S, Marberger M, Vutuc C, Micksche M.
Gsur A, et al. Among authors: schatzl g.
Int J Cancer. 2000 Aug 1;87(3):434-7. doi: 10.1002/1097-0215(20000801)87:3<434::aid-ijc19>3.0.co;2-g.
Int J Cancer. 2000.
PMID: 10897051
Free article.